NASDAQ: COYA - Coya Therapeutics, Inc.

छह महीने के लिए लाभप्रदता: -2.15%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Coya Therapeutics, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis.

अधिक जानकारी
The company's product candidates in IND-enabling studies include COYA 301, a low-dose interleukin 2 Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an antigen directed Treg-derived exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

EBITDA -0.000695
EV/EBITDA 12.55
IPO date 2022-12-29
ISIN US22407B1089
Industry Biotechnology
P/BV -5.62
P/S 12.11
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.006
Сайт https://www.coyatherapeutics.com
Цена ао 8.85
Число акций ао 0.01016 млрд
प्रति दिन मूल्य परिवर्तन: +8.23% (5.47)
प्रति सप्ताह मूल्य परिवर्तन: +12.98% (5.24)
प्रति माह मूल्य परिवर्तन: -10.98% (6.65)
3 महीने में कीमत में बदलाव: -12.43% (6.76)
छह महीने में कीमत में बदलाव: -2.15% (6.05)
प्रति वर्ष मूल्य परिवर्तन: -20.11% (7.41)
3 वर्षों में मूल्य परिवर्तन: 0% (5.92)
5 वर्षों में मूल्य परिवर्तन: 0% (5.92)
10 वर्षों में मूल्य परिवर्तन: 0% (5.92)
वर्ष की शुरुआत से मूल्य परिवर्तन: -20.11% (7.41)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 12.11 1
P/BV 2.04 7
P/E 0 0
EV/EBITDA -5.46 0
कुल: 4.75

क्षमता

नाम अर्थ श्रेणी
ROA, % -19.35 0
ROE, % -22.41 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -1.77 10
कुल: 8.4

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 0 0
लाभप्रदता Ebitda, % 1037.17 10
लाभप्रदता EPS, % 938.19 10
कुल: 8
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Greenlight Capital, Inc. 1274026 8.72
AIGH Capital Management LLC 1031977 7.07
CM Management, LLC 100000 0.68
Vanguard Group Inc 97152 0.67
Worth Venture Partners, LLC 92667 0.63
Geode Capital Management, LLC 92465 0.63
Prelude Capital Management LLC 35770 0.24
Blackrock Inc. 21775 0.15
Potomac Capital Management, Inc. 21101 0.14
Citadel Advisors Llc 16592 0.11

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
iShares Micro-Cap ETF 0.02048 11.903735012508 1.54048



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Dr. Howard Berman Ph.D. Chairman & CEO 833.75k 1974 (50 साल)
Mr. David S. Snyder CFO & COO 610.94k 1960 (64 वर्ष)
Dr. Fred Grossman D.O., FAPA President & Chief Medical Officer 610.63k 1962 (62 वर्ष)
Dr. Gregory MacMichael Ph.D. Chief Technical Officer N/A 1956 (68 साल)
Dr. Michelle Frazier Ph.D. Senior Vice President of Regulatory Affairs N/A
Mr. Aaron Thome Ph.D. Head of Neuroinflammation Platform N/A
Dr. Arun Swaminathan Ph.D. Chief Business Development Officer N/A

पता: United States, Houston. TX, 5850 San Felipe Street - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.coyatherapeutics.com